Tracing Side Effects to Their Source

Tracing side effects to their source requires a unique billing code for each biological medicine.

Que Es La Extrapolacion de Indicaciones?

Y debe ser permitida con los medicamentos biologicos?

CMS Oncology Care Model

Transparent Biosimilar Labeling

Physicians need clear data to safely prescribe biosimilar medications.

Which Patients are Sick Enough for a Hepatitis C Cure?

Under many health plans, only the sickest can receive the cure they need.

Informing Physicians About Biosimilar Substitution

It’s a small price to pay for patient safety.

When Cancer Cost-Sharing Turns Toxic

Are insurers cost-shifting policies pricing cancer patients out of care?

The Path to a Hepatitis C Cure

Breakthrough therapies offer millions of Americans with hepatitis the long-awaited chance for a cure. But complex prior authorization requirements make accessing these cures difficult –

Read More

Which Infants are More Vulnerable to Respiratory Syncytial Virus

Lengthy Prior Authorization Processes

Lengthy prior authorization processes delay patient access to vital medications.

Back to Top